Tenax Therapeutics (TENX) EBITDA Margin (2010 - 2015)
Tenax Therapeutics recorded quarterly EBITDA Margin of 9771.28% in Q2 2015, up 1531.67% quarter-over-quarter from 682.51% in Q2 2013.
Tenax Therapeutics' EBITDA Margin history runs 5 years deep, the most recent figure standing at 9771.28% for Q2 2015.
- In Q2 2015, EBITDA Margin changed N/A year-over-year to 9771.28%; the TTM figure through Jun 2016 stood at 46497.11% (up 4506378.0% YoY), while the FY2015 annual figure was 32266.4%, changed N/A from the prior year.
- EBITDA Margin came in at 9771.28% for Q2 2015 at Tenax Therapeutics, up from 682.51% in the prior quarter.
- In the past five years, EBITDA Margin ranged from a high of 10360.51% in Q1 2011 to a low of 9761.9% in Q3 2011.
- A 4-year average of 805.69% and a median of 682.51% in 2013 frame the typical range for EBITDA Margin.
- On a YoY basis, EBITDA Margin climbed as much as 914614 bps in 2012 and fell as far as 1164303 bps in 2012.
- Tenax Therapeutics' EBITDA Margin stood at 2158.73% in 2011, then soared by 94 bps to 132.62% in 2012, then plunged by 415 bps to 682.51% in 2013, then soared by 1532 bps to 9771.28% in 2015.
- According to Business Quant data, EBITDA Margin over the past three periods registered 9771.28%, 682.51%, and 719.97% for Q2 2015, Q2 2013, and Q1 2013 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | -6.43% |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 38.10% |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 18.35% |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 17.24% |
| 10 | Tenax Therapeutics | 542.72 Mn | 542.72 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2015 | 9,771.28% |
| Apr 30, 2013 | -682.51% |
| Jan 31, 2013 | -719.97% |
| Oct 31, 2012 | -132.62% |
| Jul 31, 2012 | -615.75% |
| Apr 30, 2012 | -2,067.33% |
| Jan 31, 2012 | -1,282.52% |
| Oct 31, 2011 | -2,158.73% |
| Jul 31, 2011 | -9,761.90% |
| Apr 30, 2011 | 6,152.14% |
| Jan 31, 2011 | 10,360.51% |
| Oct 31, 2010 | 7,582.16% |